Skip to main content
NCBI home page
Journal of Virology logoLink to Journal of Virology
. 1980 Sep;35(3):757–765. doi: 10.1128/jvi.35.3.757-765.1980

Activation of mouse lymphocytes by vesicular stomatitis virus.

G W Goodman-Snitkoff, J J McSharry
PMCID: PMC288870  PMID: 6252336

Abstract

Vesicular stomatitis virus (VSV) is a mitogen for mouse spleen cells, and infectious virus is not required for mitogenesis. At concentrations between 10 and 100 microgram per culture, VSV stimulated DNA synthesis and blast transformation. Maximal activation by VSV occurred 48 h after culture initiation. Spleen cells depleted of T-lymphocytes by treatment with anti-Thy 1.2 and complement and those obtained from congenitally athymic BALB/c nu/nu mice were activated by VSV, suggesting that VSV is a B-cell mitogen. Activation of spleen cells was independent of the host in which the virus was grown, since VSV grown in BHK-21, HKCC, or MDBK cells was mitogenic. The mitogenesis was specific for VSV, since MDBK cell-grown WSN influenza virus was not a mitogen in this in vitro activation system, VSV-specific antibody prevented VSV mitogenesis, and VSV was mitogenic for spleen cells from C3H/HeJ mice which were resistant to mitogenesis by endotoxin.

Full text

PDF
757

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Beckman L. D., Caliguiri L. A., Lilly L. S. Cleavage site alterations in poliovirus-specific precursor proteins. Virology. 1976 Aug;73(1):216–227. doi: 10.1016/0042-6822(76)90076-3. [DOI] [PubMed] [Google Scholar]
  2. Biberfeld G., Gronowicz E. Mycoplasma pneumoniae is a polyclonal B-cell activator. Nature. 1976 May 20;261(5557):238–239. doi: 10.1038/261238a0. [DOI] [PubMed] [Google Scholar]
  3. Bloom B. R., Jimenez L., Marcus P. I. A plaque assay for enumerating antigen-sensitive cells in delayed-type hypersensitivity. J Exp Med. 1970 Jul 1;132(1):16–30. doi: 10.1084/jem.132.1.16. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bloom B. R., Senik A., Stoner G., Ju G., Nowakowski M., Kano S., Jimenez L. Studies on the interactions between viruses and lymphocytes. Cold Spring Harb Symp Quant Biol. 1977;41(Pt 1):73–83. doi: 10.1101/sqb.1977.041.01.011. [DOI] [PubMed] [Google Scholar]
  5. Brochier J., Bona C., Ciorbaru R., Revillard J. P., Chedid L. A human T-independent B lymphocyte mitogen extracted from Nocardia opaca. J Immunol. 1976 Nov;117(5 Pt 1):1434–1439. [PubMed] [Google Scholar]
  6. Butchko G. M., Armstrong R. B., Martin W. J., Ennis F. A. Influenza A viruses of the H2N2 subtype are lymphocyte mitogens. Nature. 1978 Jan 5;271(5640):66–67. doi: 10.1038/271066a0. [DOI] [PubMed] [Google Scholar]
  7. Caliguiri L. A., Gerstein H. Subclasses of ribonucleoproteins in influenza virus-infected cells. Virology. 1978 Oct 1;90(1):119–132. doi: 10.1016/0042-6822(78)90339-2. [DOI] [PubMed] [Google Scholar]
  8. Cartwright B., Smale C. J., Brown F. Surface structure of vesicular stomatitis virus. J Gen Virol. 1969 Jul;5(1):1–10. doi: 10.1099/0022-1317-5-1-1. [DOI] [PubMed] [Google Scholar]
  9. Choppin P. W., Compans R. W. Phenotypic mixing of envelope proteins of the parainfluenza virus SV5 and vesicular stomatitis virus. J Virol. 1970 May;5(5):609–616. doi: 10.1128/jvi.5.5.609-616.1970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Choppin P. W. Replication of influenza virus in a continuous cell line: high yield of infective virus from cells inoculated at high multiplicity. Virology. 1969 Sep;39(1):130–134. doi: 10.1016/0042-6822(69)90354-7. [DOI] [PubMed] [Google Scholar]
  11. Ciorbaru R., Adam A., Petit J. F., Lederer E., Bona C., Chedid L. Isolation of mitogenic and adjuvant active fractions from various species of Nocardiae. Infect Immun. 1975 Feb;11(2):257–264. doi: 10.1128/iai.11.2.257-264.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Goodman G. W., Sultzer B. M. Endotoxin protein is a mitogen and polyclonal activator of human B lymphocytes. J Exp Med. 1979 Mar 1;149(3):713–723. doi: 10.1084/jem.149.3.713. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Goodman G. W., Sultzer B. M. Mild alkaline hydrolysis of lipopolysaccharide endotoxin enhances its mitogencity for murine B cells. Infect Immun. 1977 Jul;17(1):205–214. doi: 10.1128/iai.17.1.205-214.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Goodman M. G., Weigle W. O. Nonspecific activation of murine lymphocytes. I. Proliferation and polyclonal activation induced by 2-mercaptoethanol and alpha-thioglycerol. J Exp Med. 1977 Mar 1;145(3):473–489. doi: 10.1084/jem.145.3.473. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Greenberger J. S., Phillips S. M., Stephenson J. R., Aaronson S. A. Induction of mouse type-C RNA virus by lipopolysaccharide. J Immunol. 1975 Jul;115(1):317–320. [PubMed] [Google Scholar]
  16. Hale A. H., Witte O. N., Baltimore D., Eisen H. N. Vesicular stomatitis virus glycoprotein is necessary for H-2-restricted lysis of infected cells by cytotoxic T lymphocytes. Proc Natl Acad Sci U S A. 1978 Feb;75(2):970–974. doi: 10.1073/pnas.75.2.970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Holmes K. V., Choppin P. W. On the role of the response of the cell membrane in determining virus virulence. Contrasting effects of the parainfluenza virus SV5 in two cell types. J Exp Med. 1966 Sep 1;124(3):501–520. doi: 10.1084/jem.124.3.501. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Kelley J. M., Emerson S. U., Wagner R. R. The glycoprotein of vesicular stomatitis virus is the antigen that gives rise to and reacts with neutralizing antibody. J Virol. 1972 Dec;10(6):1231–1235. doi: 10.1128/jvi.10.6.1231-1235.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Kendall P. A., Hutchins D. The effect of thiol compounds on lymphocytes stimulated in culture. Immunology. 1978 Jul;35(1):189–201. [PMC free article] [PubMed] [Google Scholar]
  20. Kirchner H., Darai G., Hirt H. M., Keyssner K., Munk K. In vitro mitogenic stimulation of murine spleen cells by herpes simplex virus. J Immunol. 1978 Feb;120(2):641–645. [PubMed] [Google Scholar]
  21. Kirchner H., Hirt H. M., Kleinicke C., Munk K. Replication of herpes simplex virus in mouse spleen cell cultures stimulated by lipopolysaccharide. J Immunol. 1976 Nov;117(5 PT2):1753–1756. [PubMed] [Google Scholar]
  22. Klenk H. D., Choppin P. W. Glycolipid content of vesicular stomatitis virus grown in baby hamster kidney cells. J Virol. 1971 Mar;7(3):416–417. doi: 10.1128/jvi.7.3.416-417.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  24. Lazzarini R. A., Weber G. H., Johnson L. D., Stamminger G. M. Covalently linked message and anti-message (genomic) RNA from a defective vesicular stomatitis virus particle. J Mol Biol. 1975 Sep 25;97(3):289–307. doi: 10.1016/s0022-2836(75)80042-8. [DOI] [PubMed] [Google Scholar]
  25. McSharry J. J., Choppin P. W. Biological properties of the VSV glycoprotein. 1. Effects of the isolated glycoprotein on host macromolecular synthesis. Virology. 1978 Jan;84(1):172–182. doi: 10.1016/0042-6822(78)90229-5. [DOI] [PubMed] [Google Scholar]
  26. McSharry J. J., Compans R. W., Choppin P. W. Proteins of vesicular stomatitis virus and of phenotypically mixed vesicular stomatitis virus-simian virus 5 virions. J Virol. 1971 Nov;8(5):722–729. doi: 10.1128/jvi.8.5.722-729.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. McSharry J. J., Ledda C. A., Freiman H. J., Choppin P. W. Biological properties of the VSV glycoprotein. II. Effects of the host cell and of the glycoprotein carbohydrate composition on hemagglutination. Virology. 1978 Jan;84(1):183–188. doi: 10.1016/0042-6822(78)90230-1. [DOI] [PubMed] [Google Scholar]
  28. McSharry J. J., Wagner R. R. Lipid composition of purified vesicular stomatitis viruses. J Virol. 1971 Jan;7(1):59–70. doi: 10.1128/jvi.7.1.59-70.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Melchers F., Braun V., Galanos C. The lipoprotein of the outer membrane of Escherichia coli: a B-lymphocyte mitogen. J Exp Med. 1975 Aug 1;142(2):473–482. doi: 10.1084/jem.142.2.473. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Mochizuki D., Hedrick S., Watson J., Kingsbury D. T. The interaction of Herpes Simplex Virus with murine lymphocytes. I. Mitogenic properties of herpes simplex virus. J Exp Med. 1977 Dec 1;146(6):1500–1510. doi: 10.1084/jem.146.6.1500. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Moroni C., Schumann G. Mitogen induction of murine C-type viruses. II. Effect of B-lymphocyte mitogens. Virology. 1976 Aug;73(1):17–22. doi: 10.1016/0042-6822(76)90056-8. [DOI] [PubMed] [Google Scholar]
  32. Möller G., Landwall P. The polyclonal B-cell-activating property of protein A is not due to its interaction with the FC part of immunoglobulin receptors. Scand J Immunol. 1977;6(4):357–366. doi: 10.1111/j.1365-3083.1977.tb00405.x. [DOI] [PubMed] [Google Scholar]
  33. Naot Y., Ginsburg H. Activation of B lymphocytes by mycoplasma mitogen(s). Immunology. 1978 Apr;34(4):715–720. [PMC free article] [PubMed] [Google Scholar]
  34. Peavy D. L., Shands J. W., Jr, Adler W. H., Smith R. T. Mitogenicity of bacterial endotoxins: characterization of the mitogenic principle. J Immunol. 1973 Aug;111(2):352–357. [PubMed] [Google Scholar]
  35. Phillips S. M., Stephenson J. R., Greenberger J. S., Lane P. E., Aaronson S. A. Release of xenotropic type C RNA virus in response to lipopolysaccharide: acitivity of lipid-A portion upon B lymphocytes. J Immunol. 1976 Apr;116(4):1123–1128. [PubMed] [Google Scholar]
  36. Pinter A., Compans R. W. Sulfated components of enveloped viruses. J Virol. 1975 Oct;16(4):859–866. doi: 10.1128/jvi.16.4.859-866.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Sakane T., Green I. Protein A from Staphylococcus aureus-a mitogen for human T lymphocytes and B lymphocytes but not L lymphocytes. J Immunol. 1978 Jan;120(1):302–311. [PubMed] [Google Scholar]
  38. Scher I., Strong D. M., Ahmed A., Knudsen R. C., Sell K. W. Specific murine B-cell activation by synthetic single-and double-stranded polynucleotides. J Exp Med. 1973 Dec 1;138(6):1545–1563. doi: 10.1084/jem.138.6.1545. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Sultzer B. M., Goodman G. W. Endotoxin protein: a B-cell mitogen and polyclonal activator of C3H/HeJ lymphocytes. J Exp Med. 1976 Sep 1;144(3):821–827. doi: 10.1084/jem.144.3.821. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Sultzer B. M., Nilsson B. S. PPD tuberculin--a B-cell mitogen. Nat New Biol. 1972 Dec 13;240(102):198–200. doi: 10.1038/newbio240198a0. [DOI] [PubMed] [Google Scholar]
  41. Watanabe T., Fathman C. G., Coutinho A. Clonal growth of T cells in vitro: preliminary attempts to a quantitative approach. Immunol Rev. 1977;35:3–37. doi: 10.1111/j.1600-065x.1977.tb00233.x. [DOI] [PubMed] [Google Scholar]
  42. Wheelock E. F., Toy S. T. Participation of lymphocytes in viral infections. Adv Immunol. 1973;16:123–184. doi: 10.1016/s0065-2776(08)60297-7. [DOI] [PubMed] [Google Scholar]
  43. Woodruff J. F., Woodruff J. J. T lymphocyte interaction with viruses and virus-infected tissues. Prog Med Virol. 1975;19:120–160. [PubMed] [Google Scholar]
  44. Zinkernagel R. M., Adler B., Holland J. J. Cell-mediated immunity to vesicular stomatitis virus infections in mice. Exp Cell Biol. 1978;46(1-2):53–70. doi: 10.1159/000162882. [DOI] [PubMed] [Google Scholar]
  45. Zinkernagel R. M., Althage A., Holland J. Target antigens for H-2-restricted vesicular stomatitis virus-specific cytotoxic T cells. J Immunol. 1978 Aug;121(2):744–748. [PubMed] [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES